Literature DB >> 23433809

Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Jeannia J Fu1, Nickolas D Zaller, Michael A Yokell, Alexander R Bazazi, Josiah D Rich.   

Abstract

The World Health Organization classifies methadone as an essential medicine, yet methadone maintenance therapy remains widely unavailable in criminal justice settings throughout the United States. Methadone maintenance therapy is often terminated at the time of incarceration, with inmates forced to withdraw from this evidence-based therapy. We assessed whether these forced withdrawal policies deter opioid-dependent individuals in the community from engaging methadone maintenance therapy in two states that routinely force inmates to withdraw from methadone (N = 205). Nearly half of all participants reported that concern regarding forced methadone withdrawal during incarceration deterred them engaging methadone maintenance therapy in the community. Participants in the state where more severe methadone withdrawal procedures are used during incarceration were more likely to report concern regarding forced withdrawal as a treatment deterrent. Methadone withdrawal policies in the criminal justice system may be a broader treatment deterrent for opioid-dependent individuals than previously realized. Redressing this treatment barrier is both a health and human rights imperative.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433809      PMCID: PMC3695471          DOI: 10.1016/j.jsat.2012.10.005

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  26 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 2.  The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

Authors:  Dagmar Hedrich; Paula Alves; Michael Farrell; Heino Stöver; Lars Møller; Soraya Mayet
Journal:  Addiction       Date:  2012-03       Impact factor: 6.526

3.  Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.

Authors:  R Douglas Bruce; Rebecca A Schleifer
Journal:  Int J Drug Policy       Date:  2008-01-15

4.  Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Shannon Gwin Mitchell; Barry S Brown
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

5.  Premature discharge from methadone treatment: patient perspectives.

Authors:  Heather Schacht Reisinger; Robert P Schwartz; Shannon Gwin Mitchell; James A Peterson; Sharon M Kelly; Kevin E O'Grady; Erica A Marrari; Barry S Brown; Michael H Agar
Journal:  J Psychoactive Drugs       Date:  2009-09

6.  Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

7.  Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.

Authors:  Shannon Gwin Mitchell; Sharon M Kelly; Barry S Brown; Heather Schacht Reisinger; James A Peterson; Adrienne Ruhf; Michael H Agar; Robert P Schwartz
Journal:  J Psychoactive Drugs       Date:  2009-06

8.  A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Kevin E O'Grady
Journal:  Crim Justice Behav       Date:  2008

9.  A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.

Authors:  Valerie A Gruber; Kevin L Delucchi; Anousheh Kielstein; Steven L Batki
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

10.  Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.

Authors:  G Serpelloni; M P Carrieri; G Rezza; S Morganti; M Gomma; N Binkin
Journal:  AIDS Care       Date:  1994
View more
  14 in total

1.  Optimizing continuity of care throughout incarceration: case and opportunities.

Authors:  Fiona Kouyoumdjian; Jill Wiwcharuk; Samantha Green
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

2.  Understanding interactions of formerly incarcerated HIV-positive men and transgender women with substance use treatment, medical, and criminal justice systems.

Authors:  Nina T Harawa; Bita Amani; Jane Rohde Bowers; Jennifer N Sayles; William Cunningham
Journal:  Int J Drug Policy       Date:  2017-08-09

Review 3.  Update on Barriers to Pharmacotherapy for Opioid Use Disorders.

Authors:  Anjalee Sharma; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Robert P Schwartz
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

4.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

5.  Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.

Authors:  Kelly E Moore; Walter Roberts; Holly H Reid; Kathryn M Z Smith; Lindsay M S Oberleitner; Sherry A McKee
Journal:  J Subst Abuse Treat       Date:  2018-12-15

6.  The impact of the opioid crisis on U.S. state prison systems.

Authors:  Christy K Scott; Michael L Dennis; Christine E Grella; Allison F Mischel; John Carnevale
Journal:  Health Justice       Date:  2021-07-24

7.  The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.

Authors:  Redonna K Chandler; Matthew S Finger; David Farabee; Robert P Schwartz; Timothy Condon; Laura J Dunlap; Gary A Zarkin; Kathryn McCollister; Ryan D McDonald; Eugene Laska; David Bennett; Sharon M Kelly; Maureen Hillhouse; Shannon G Mitchell; Kevin E O'Grady; Joshua D Lee
Journal:  Contemp Clin Trials       Date:  2016-05-11       Impact factor: 2.226

8.  Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.

Authors:  Kirsten E Smith; Martha D Tillson; Michele Staton; Erin M Winston
Journal:  Drug Alcohol Depend       Date:  2020-01-09       Impact factor: 4.492

9.  Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.

Authors:  Kelly E Moore; Lindsay Oberleitner; Kathryn M Z Smith; Kathleen Maurer; Sherry A McKee
Journal:  J Addict Med       Date:  2018 Mar/Apr       Impact factor: 3.702

10.  Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.

Authors:  Erica Morse; Ingrid A Binswanger; Emmeline Taylor; Caroline Gray; Matthew Stimmel; Christine Timko; Alex H S Harris; David Smelson; Andrea K Finlay
Journal:  J Subst Abuse Treat       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.